Advertisement

Neurosurgical Review

, Volume 33, Issue 3, pp 375–381 | Cite as

Far-distant metastases along the CSF pathway of glioblastoma multiforme during continuous low-dose chemotherapy with temozolomide and celecoxib

  • Marcel Seiz
  • Ingo Nölte
  • Ioannis Pechlivanis
  • Christian F. FreyschlagEmail author
  • Kirsten Schmieder
  • Peter Vajkoczy
  • Jochen Tuettenberg
Case Report

Abstract

Glioblastoma multiforme is the most common and most malignant primary brain tumour. Prognosis after diagnosis remains poor despite recent advances in adjuvant therapy. Treatment of choice is gross surgical resection and combined radio-chemotherapy with temozolomide as chemotherapeutic agent. Experimental continuous low-dose chemotherapy with temozolomide in combination with a cyclooxygenase-2 inhibitor has shown encouraging effects on progression-free survival and overall survival in patients, but leads to a high proportion of distant recurrences. Here, we describe extreme far-distant metastases along the neural axis of glioblastoma multiforme in four patients receiving metronomic antiangiogenic chemotherapy and review the literature to discuss possible mechanisms.

Keywords

Far-distant metastases Glioblastoma multiforme Antiangiogenic therapy 

Notes

References

  1. 1.
    Aichholzer M, Mazal PR, Haberler C, Dietrich W, Bertalanffy A, Roessler K et al (2001) Epidural metastasis of a glioblastoma after stereotactic biopsy: case report. Minim Invasive Neurosurg 44:175–177CrossRefPubMedGoogle Scholar
  2. 2.
    Arita N, Taneda M, Hayakawa T (1994) Leptomeningeal dissemination of malignant gliomas. Incidence, diagnosis and outcome. Acta Neurochir 126:84–92CrossRefGoogle Scholar
  3. 3.
    Asano K, Kubo O, Tajika Y, Takakura K, Suzuki S (2000) Expression of adherin and CSF dissemination in malignant astrocytic tumors. Neurosurg Rev 23:39–44CrossRefPubMedGoogle Scholar
  4. 4.
    Barbagallo GM, Jenkinson MD, Brodbelt AR (2008) 'Recurrent' glioblastoma multiforme, when should we reoperate? Br J Neurosurg 22:452–455CrossRefPubMedGoogle Scholar
  5. 5.
    Beauchesne P, Soler C, Mosnier JF (2000) Diffuse vertebral body metastasis from a glioblastoma multiforme: a technetium-99 m sestamibi single-photon emission computerized tomography study. J Neurosurg 93:887–890CrossRefPubMedGoogle Scholar
  6. 6.
    Bouillot-Eimer S, Loiseau H, Vital A (2005) Subcutaneous tumoural seeding from a glioblastoma following stereotactic biopsy: case report and review of the literature. Clin Neuropathol 24:247–251PubMedGoogle Scholar
  7. 7.
    Brockmann MA, Ulbricht U, Grüner K, Fillbrandt R, Westphal M, Lamszus K (2003) Glioblastoma and cerebral microvascular endothelial cell migration in response to tumor-associated growth factors. Neurosurgery 52:1391CrossRefPubMedGoogle Scholar
  8. 8.
    Burger PC, Dubois PJ, Schold SC Jr, Smith KR Jr, Odom GL, Crafts DC et al (1983) Computerized tomographic and pathologic studies of the untreated, quiescent, and recurrent glioblastoma multiforme. J Neurosurg 58:159–169CrossRefPubMedGoogle Scholar
  9. 9.
    Cervio A, Piedimonte F, Salaberry J, Alcorta SC, Salvat J, Diez B et al (2001) Bone metastasis from secondary glioblastoma multiforme: a case report. J Neurooncol 52:141–148CrossRefPubMedGoogle Scholar
  10. 10.
    De Angelis LM (2001) Brain tumours. N Engl J Med 344:114–123CrossRefGoogle Scholar
  11. 11.
    Ebos JM, Lee CR, Cruz-Munoz W, Bjarnason GA, Christensen JG, Kerbel RS (2009) Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis. Cancer Cell 15:232–239CrossRefPubMedGoogle Scholar
  12. 12.
    Erlich SS, Davis RL (1978) Spinal subarachnoid metastasis from primary intracranial glioblastoma multiforme. Cancer 42:2854–2864CrossRefPubMedGoogle Scholar
  13. 13.
    Fakhrai N, Czech T, Diekmann K, Fazeny-Dörner B, Birner P, Hainfellner JA et al (2004) Glioblastoma with spinal seeding. Strahlenther Onkol 180:455–457CrossRefPubMedGoogle Scholar
  14. 14.
    Grabb PA, Albright AL, Pang D (1992) Dissemination of supratentorial malignant gliomas via the cerebrospinal fluid in children. Neurosurgery 30:64–71CrossRefPubMedGoogle Scholar
  15. 15.
    Holash J, Wiegand SJ, Yancopoulos GD (1999) New model of tumor angiogenesis: dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF. Oncogene 18:5356–5362CrossRefPubMedGoogle Scholar
  16. 16.
    Juliano RL (2002) Signal transduction by cell adhesion receptors and cytoskeleton: functions of integrins, cadherins, selectins, and immunoglobulin-superfamily members. Annu Rev Pharmacol Toxicol 42:283–323CrossRefPubMedGoogle Scholar
  17. 17.
    Kumar R, Jain R, Tandon V (1999) Thalamic glioblastoma with cerebrospinal fluid dissemination in the peritoneal cavity. Pediatr Neurosurg 31:242–245CrossRefPubMedGoogle Scholar
  18. 18.
    Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D et al (2001) Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 61:6624–6628PubMedGoogle Scholar
  19. 19.
    Lamszus K, Brockmann MA, Eckerich C, Bohlen P, May C, Mangold U et al (2005) Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin. Clin Cancer Res 11:4934–4940CrossRefPubMedGoogle Scholar
  20. 20.
    Ley A, Campillo D, Oliveras C (1961) Extracranial metastases of glioblastoma multiforme. J Neurosurg 18:313–330CrossRefPubMedGoogle Scholar
  21. 21.
    Longee DC, Friedman HS, Phillips PC, Oakes WJ, Heffez D (1991) Osteoblastic metastases from astrocytomas: a report of two cases. Med Pediatr Oncol 19:318–324CrossRefPubMedGoogle Scholar
  22. 22.
    Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83:337–376PubMedGoogle Scholar
  23. 23.
    Martin K, Akinwunmi J, Roopmai HK et al (1995) Nonexpression of CD15 by neoplastic glia: a barrier to metastasis? Anticancer Res 15:1159–1166PubMedGoogle Scholar
  24. 24.
    Mathieu V, De Nève N, Le Mercier M, Dewelle J, Gaussin JF, Dehoux M, Kiss R, Lefranc F (2008) Combining bevacizumab with temozolomide increases the antitumor efficacy of temozolomide in a human glioblastoma orthotopic xenograft model. Neoplasia 10:1383–1392PubMedGoogle Scholar
  25. 25.
    Mihara F, Rothman IM, MI NY, Kristt D (1994) Vertebral body metastasis of glioblastoma multiforme with epidural mass formation. Contrast enhanced MRI study. Clin Imaging 18:386–389CrossRefPubMedGoogle Scholar
  26. 26.
    Morley TP (1959) The recovery of tumour cells from venous blood draining cerebral gliomas. Can J Surg 2:363–365PubMedGoogle Scholar
  27. 27.
    Mujic A, Hunn A, Taylor AB, Lowenthal RM (2006) Extracranial metastases of a glioblastoma multiforme to the pleura, small bowel and pancreas. J Clin Neurosci 13:677–681CrossRefPubMedGoogle Scholar
  28. 28.
    Paez-Ribes M, Allen E, Hudock J et al (2009) Antiangiogenic therapy elicits malignant progression of tumors to increased local invasion and distant metastasis. Cancer Cell 15:220–231CrossRefPubMedGoogle Scholar
  29. 29.
    Pasquier B, Pasquier D, Ngolet A, Panh MH, Couderc P (1980) Extraneural metastases of astrocytomas and glioblastomas: clinicopathological study and review of literature. Cancer 45:112–125CrossRefPubMedGoogle Scholar
  30. 30.
    Pierallini A, Caramia F, Piatella MC, Pantano P, Santero A, Di Stefano D et al (1999) Metastasis along the stereotactic biopsy trajectory in glioblastoma multiforme. Acta Neurochir 141:1011–1012CrossRefGoogle Scholar
  31. 31.
    Saito R, Kumabe T, Jokura H, Shirane R, Yoshimoto T (2003) Symptomatic spinal dissemination of malignant astrocytoma. J Neurooncol 61:227–235CrossRefPubMedGoogle Scholar
  32. 32.
    Salazar OM, Rubin P (1976) The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 2:627–63725Google Scholar
  33. 33.
    Smith DR, Hardman JM, Earle KM (1969) Metastasizing neuroectodermal tumours of the central nervous system. J Neurosurg 31:50–58CrossRefPubMedGoogle Scholar
  34. 34.
    Steinmetz MP, Barnett GH, Kim BS, Chidel MA, Suh JH (2001) Metastatic seeding of the stereotactic biopsy tract in glioblastoma multiforme: case report and review of the literature. J Neurooncol 55:167–171CrossRefPubMedGoogle Scholar
  35. 35.
    Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ et al (2005) Radiotherapy plus concomitant and adjuvant temozolomide for gliobastoma. N Engl J Med 35:978–996Google Scholar
  36. 36.
    Taha M, Ahamd A, Wharton S, Jellinek D (2005) Extra-cranial metastasis of glioblastoma multiforme presenting as acute parotitis. Br J Neurosurg 19:248–251CrossRefGoogle Scholar
  37. 37.
    Tuettenberg J, Grobholz R, Seiz M, Brockmann MA, Lohr F, Wenz F et al (2009) Pattern of tumour recurrence in patients with glioblastoma multiforme undergoing anti-angiogenic therapy with metronomic temozolomide and COX-II-inhibition. J Cancer Res Clin Oncol 135(9):1239–1244CrossRefPubMedGoogle Scholar
  38. 38.
    Tuettenberg J, Grobholz R, Korn T, Wenz F, Erber R, Vajkoczy P (2005) Continuous low dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy in glioblastoma multiforme. J Cancer Res Clin Oncol 131:31–40CrossRefPubMedGoogle Scholar
  39. 39.
    Utsuki S, Tanaka S, Oka H, Iwamoto K, Sagiuchi T, Fujii K (2005) Glioblastoma multiforme metastasis to the axis. Case report. J Neurosurg 102:540–542CrossRefPubMedGoogle Scholar
  40. 40.
    Vajkoczy P, Knyazev P, Kunkel A, Capelle HH, Behrndt S, von Tengg-Kobligk H et al (2006) Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival. Proc Natl Acad Sci USA 103:5799–5804CrossRefPubMedGoogle Scholar
  41. 41.
    Vertosick FT Jr, Selker RG (1990) Brain stem and spinal metastases of supratentorial glioblastoma multiforme: a clinical series. Neurosurgery 27:516–521CrossRefPubMedGoogle Scholar
  42. 42.
    Wick W, Naumann U, Weller M (2006) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341–349CrossRefPubMedGoogle Scholar
  43. 43.
    Yung WA, Horten BC, Shapiro WR (1980) Meningeal gliomatosis: a review of 12 cases. Ann Neurol 8:605–608CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2010

Authors and Affiliations

  • Marcel Seiz
    • 1
  • Ingo Nölte
    • 2
  • Ioannis Pechlivanis
    • 1
  • Christian F. Freyschlag
    • 1
    • 4
    Email author
  • Kirsten Schmieder
    • 1
  • Peter Vajkoczy
    • 3
  • Jochen Tuettenberg
    • 1
  1. 1.Department of NeurosurgeryMedical Faculty of the University of HeidelbergMannheimGermany
  2. 2.Department of NeuroradiologyMedical Faculty of the University of HeidelbergMannheimGermany
  3. 3.Department of NeurosurgeryCharité UniversitätsmedizinBerlinGermany
  4. 4.Department of NeurosurgeryUniversity Hospital Mannheim, University of HeidelbergMannheimGermany

Personalised recommendations